공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 면역형광 어세이 시장 : 성장, 동향, 예측(2020-2025년)

Immunofluorescence Assay Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 05월 상품 코드 925373
페이지 정보 영문
가격
US $ 4,250 ₩ 5,044,000 PDF (Single User License)
US $ 4,750 ₩ 5,637,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,121,000 PDF (Site License)
US $ 7,500 ₩ 8,901,000 PDF (Corporate License)


세계의 면역형광 어세이 시장 : 성장, 동향, 예측(2020-2025년) Immunofluorescence Assay Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 면역형광 어세이(Immunofluorescence Assay) 시장은 2020-2025년 5.8%의 CAGR로 추이할 것으로 예측됩니다. 장암, 게실염, 크론병, 궤양성 대장염, 염증성장질환 등 대장질환의 발생률 증가가 시장의 성장을 촉진하는 요인입니다.

세계의 면역형광 어세이 시장을 조사했으며, 시장의 개요, 제품·유형·질환·지역별 시장 규모의 추이와 예측, 시장 동향, 시장 성장요인 및 저해요인 분석, 시장 기회, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

  • 조사 성과
  • 조사의 전제조건
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장요인
    • 암 및 기타 감염증의 발생률 증가
    • 정부 및 비정부 조직에 의한 투자의 증가
  • 시장 억제요인
    • 보다 효과적인 대체품의 급증
  • Porter's Five Forces 분석
    • 신규 진출의 위협
    • 바이어의 교섭력
    • 공급업체의 교섭력
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계

제5장 시장 세분화

  • 제품별
    • 시약·키트
    • 장비
    • 항체
    • 소모품·부속품
  • 유형별
    • 간접 면역형광 검사법
    • 직접 면역형광 검사법
  • 질환별
    • 감염증
    • 자가면역질환
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동·아프리카 지역
    • 남미

제6장 경쟁 구도

  • 기업 개요
    • Thermo Fisher
    • Inova Diagnostics, Inc.
    • Bio-Rad Laboratories, Inc.
    • Abcam
    • PerkinElmer Inc.
    • Merck Millipore
    • Cell Signaling Technology
    • MEDIPAN GMBH
    • Sino Biological
    • Danaher

제7장 시장 기회 및 향후 전망

KSA 20.05.21

The Immunofluorescence Assay market studied was projected to grow with a CAGR of nearly 5.8% over the forecast period. The major factor attributing to the growth of the market is the increase in the incidence of large intestine diseases like intestinal cancer, diverticulitis, Crohn's Disease, ulcerative colitis, and inflammatory bowel disease. According to the American Association for the Advancement of Science (AAAS), the number of people suffering from inflammatory bowel diseases is three times higher than previous estimates, with sufferers also at a higher risk of developing colorectal cancer, affecting over 3 million people across Europe. Furthermore, the growing popularity of drainable ostomy bags and increasing investments in product development is boosting the market growth. However, the gaining popularity of the alternative procedures is the major drawback of the market growth

Key Market Trends

Indirect Immunofluorescence Segment is Dominating the Immunofluorescence Assay Market.

  • The advantages of indirect immunofluorescence are high sensitivity, easy to change signal color based on changing the second antibody which can get commercially. The labeled second antibodies are conveniently obtained. Secondary antibodies are relatively inexpensive compared to primary antibodies. Further cost savings may be made by using the same conjugated secondary antibody to detect different primary antibodies.
  • Apart from the above-mentioned factors, other factors boosting the segment growth are increasing incidence of cancer and infectious diseases where these assays are used to diagnose. According to the World Health Organization, the global cancer burden is expected to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide developed cancer during their lifetime, and one in 8 men and one in 11 women die from the disease. Furthermore, the growing investments in research and development programs by the biotechnology companies is boosting the segment growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, high prevalence of infectious diseases and cancer in the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and increase in number of research partnerships are some of the drivers expected to increase the market growth. In this region the United States has the maximum share due to supportive healthcare policies, high number of patients, and a developed healthcare market. According to National Institutes of Health (NIH), in 2018, an estimated 1,735,350 new cases of cancer will be detected in the United States and 609,640 people will die from the disease. The statistics prove that the prevalence of cancer is high in the country and this boosts the market growth.

Competitive Landscape

The Immunofluorescence Assay market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Thermo Fisher, Inova Diagnostics, Inc., Bio-Rad Laboratories, Inc., Abcam, PerkinElmer Inc., Merck Millipore, Cell Signaling Technology, MEDIPAN GMBH, Sino Biological, Danaher.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Defintion
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Cancer and Other Infectious Diseases
    • 4.2.2 Growing Investments By Government and Non-government Organizations
  • 4.3 Market Restraints
    • 4.3.1 Upsurge of Alternative Tests Which are More Effective
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Reagents and Kits
    • 5.1.2 Instruments
    • 5.1.3 Consumables & Accessories
  • 5.2 By Type
    • 5.2.1 Indirect Immunofluorescence
    • 5.2.2 Direct Immunofluorescence
  • 5.3 By Application
    • 5.3.1 Cancer
    • 5.3.2 Infectious Diseases
    • 5.3.3 Autoimmune Diseases
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific Inc.
    • 6.1.2 Inova Diagnostics, Inc.
    • 6.1.3 Bio-Rad Laboratories, Inc.
    • 6.1.4 Abcam
    • 6.1.5 PerkinElmer Inc.
    • 6.1.6 Merck Millipore
    • 6.1.7 Cell Signaling Technology
    • 6.1.8 MEDIPAN GMBH
    • 6.1.9 Sino Biological
    • 6.1.10 Danaher Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q